ANRO Competitors & Alternatives
Compare Alto Neuroscience, Inc. with similar stocks in the same industry
Biotechnology
ANRO
Main Stock$27.07
Tradestie Score
54
Market Cap
$110.20M
Analyst Upside
+31.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$10.08
|
$1.05B | 76.8 | 41 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.13
|
$1.01B | 21.4 | 53 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$5.13
|
$997.16M | - | 47 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$2.92
|
$996.55M | - | 59 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$98.33
|
$994.20M | - | 52 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$4.97
|
$993.46M | - | 47 | Compare |
|
IMNM
Immunome, Inc.
|
$22.76
|
$987.09M | - | 51 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$8.09
|
$952.74M | - | 47 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.13
|
$951.83M | - | 56 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
More ANRO Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry